Skip to main content

5 Insightful Analyst Questions From eHealth’s Q1 Earnings Call

EHTH Cover Image

eHealth's first quarter saw notable gains, with management attributing performance to strong Medicare Advantage enrollment growth and improvements in sales and marketing processes. CEO Fran Soistman highlighted a 22% increase in Medicare submissions and expanded enrollment margins, citing the company's omnichannel approach and brand resonance as key factors. Operational enhancements, particularly in the agency fulfillment model and investments in retention initiatives, supported broader profitability improvements. Soistman emphasized, “Our customer-centric choice model is more relevant than ever,” referencing the complex Medicare plan environment and eHealth’s role in simplifying plan selection for beneficiaries.

Is now the time to buy EHTH? Find out in our full research report (it’s free).

eHealth (EHTH) Q1 CY2025 Highlights:

  • Revenue: $113.1 million vs analyst estimates of $99.72 million (21.7% year-on-year growth, 13.4% beat)
  • Adjusted EPS: -$0.27 vs analyst estimates of -$0.43 (38.1% beat)
  • Adjusted EBITDA: $12.52 million vs analyst estimates of -$7.99 million (11.1% margin, significant beat)
  • The company reconfirmed its revenue guidance for the full year of $530 million at the midpoint
  • EBITDA guidance for the full year is $47.5 million at the midpoint, above analyst estimates of $46.01 million
  • Operating Margin: 4.2%, up from -19.3% in the same quarter last year
  • Estimated Membership: 1.16 million, down 21,363 year on year
  • Market Capitalization: $125.6 million

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions eHealth’s Q1 Earnings Call

  • Ben Hendrix (RBC Capital Markets) asked about the impact of Elevance removing its Medicare Advantage plans from online platforms. CEO Fran Soistman noted eHealth’s broad carrier relationships limit the impact and expects such decisions to be revisited ahead of the next AEP.
  • Logan (Craig Hallum, for George Sutton) inquired about regulatory developments and their operational implications. Soistman described a cautiously optimistic outlook, highlighting the positive shift in the regulatory environment and the importance of upcoming CMS decisions on broker commissions.
  • Logan (Craig Hallum, for George Sutton) followed up on the Amplify platform’s trajectory. Soistman responded that Amplify will continue to find new opportunities, especially as carriers seek to outsource call center operations during low seasonal periods.
  • Jonathan Young (UBS) questioned whether recent Department of Justice litigation has changed carrier relationships. Soistman answered that it is too soon to see an impact and that sponsorship program participation varies among carriers.
  • Jonathan Young (UBS) also asked about ancillary services for carriers. Soistman said these services are still in early stages and not yet a significant revenue driver but could play a role in member retention over time.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will focus on (1) how eHealth executes its advisor ramp-up and marketing initiatives for the next AEP, (2) the adoption and impact of AI-driven enrollment tools, and (3) the effect of regulatory and commission updates on carrier and broker strategies. We will also watch for early signs of improved member retention and diversification into ancillary insurance products.

eHealth currently trades at $4.19, down from $4.68 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.

While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.